Essential Due Diligence Steps for Clinical Research M&A

Send us Fan Mail When mergers and acquisitions intersect with clinical trials, due diligence becomes a crucial step in ensuring a successful transition. In this insightful discussion, Darshan Kulkarni and Edye Edens explore the key legal and operational considerations when acquiring or merging with clinical research entities, including sponsors, sites, and CROs. A major focus of the conversation is understanding the risks associated with clinical trial sites. Many private equity investors are...